Publication | Closed Access

Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging

Hematological MalignancyChemoprevention StrategyMedicineMalignant Blood DisorderHematologyLeukemia CellsAnti-cancer AgentProspective AgentPharmacologyCell BiologyCancer Research